FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Paul Hagedoorn

Research Profile

Devices

Concepts & Ideas

Particle Size

Procedures

Administration, Inhalation

Chemicals & Drugs

Occupations

Co-author Network

Publications

TOP 3
Floris Grasmeijer; Paul Hagedoorn; Henderik W Frijlink; Anne H de Boer
Characterisation of high dose aerosols from dry powder inhalers.
Anne H de Boer; Paul Hagedoorn; Robert Woolhouse; Ed Wynn
Computational fluid dynamics (CFD) assisted performance evaluation of the Twincer™ disposable high-dose dry powder inhaler.
Paul Munnik; Anne H de Boer; Jeroen Wissink; Paul Hagedoorn; Iwan Heskamp; Wilbur de Kruijf; Cees J M van Rijn; Henderik W Frijlink; Pieter Zanen
In vivo performance testing of the novel Medspray wet aerosol inhaler.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Paul Hagedoorn (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Floris Grasmeijer; Paul Hagedoorn; Henderik W Frijlink; Anne H de Boer
Characterisation of high dose aerosols from dry powder inhalers.
International journal of pharmaceutics 2012;437(1-2):242-9.
2012: Anne H de Boer; Paul Hagedoorn; Robert Woolhouse; Ed Wynn
Computational fluid dynamics (CFD) assisted performance evaluation of the Twincer™ disposable high-dose dry powder inhaler.
The Journal of pharmacy and pharmacology 2012;64(9):1316-25.
2009: Paul Munnik; Anne H de Boer; Jeroen Wissink; Paul Hagedoorn; Iwan Heskamp; Wilbur de Kruijf; Cees J M van Rijn; Henderik W Frijlink; Pieter Zanen
In vivo performance testing of the novel Medspray wet aerosol inhaler.
Journal of aerosol medicine and pulmonary drug delivery 2009;22(4):317-21.
2008: Anne H de Boer; Jeroen Wissink; Paul Hagedoorn; Iwan Heskamp; Wilbur de Kruijf; Ralf Bünder; Pieter Zanen; Paul Munnik; Cees van Rijn; Henderik W Frijlink
In vitro performance testing of the novel Medspray wet aerosol inhaler based on the principle of Rayleigh break-up.
Pharmaceutical research 2008;25(5):1186-92.
2006: Anne H de Boer; Paul Hagedoorn; Elsbeth M Westerman; P P H Le Brun; Harry G M Heijerman; Henderik W Frijlink
Design and in vitro performance testing of multiple air classifier technology in a new disposable inhaler concept (Twincer) for high powder doses.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2006;28(3):171-8.
2006: Anne H de Boer; Paul Hagedoorn; Doetie Gjaltema; J Goede; Henderik W Frijlink
Air classifier technology (ACT) in dry powder inhalation Part 3. Design and development of an air classifier family for the Novolizer multi-dose dry powder inhaler.
International journal of pharmaceutics 2006;310(1-2):72-80.
2006: Anne H de Boer; Paul Hagedoorn; Doetie Gjaltema; J Goede; Henderik W Frijlink
Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
International journal of pharmaceutics 2006;310(1-2):81-9.
2005: Anne H de Boer; B H J Dickhoff; Paul Hagedoorn; Doetie Gjaltema; J Goede; Dorette Lambregts; Henderik W Frijlink
A critical evaluation of the relevant parameters for drug redispersion from adhesive mixtures during inhalation.
International journal of pharmaceutics 2005;294(1-2):173-84.
2004: Anne H de Boer; Paul Hagedoorn; Doetie Gjaltema; Dorette Lambregts; Meike Irngartinger; Henderik W Frijlink
The mode of drug particle detachment from carrier crystals in an air classifier-based inhaler.
Pharmaceutical research 2004;21(12):2167-74.
2004: Anne H de Boer; Paul Hagedoorn; Doetie Gjaltema; Dorette Lambregts; Meike Irngartinger; Henderik W Frijlink
The rate of drug particle detachment from carrier crystals in an air classifier-based inhaler.
Pharmaceutical research 2004;21(12):2158-66.
2004: Anne H de Boer; Doetie Gjaltema; Paul Hagedoorn; Henderik W Frijlink
Comparative in vitro performance evaluation of the Novopulmon 200 Novolizer and Budesonid-ratiopharm Jethaler: two novel budesonide dry powder inhalers.
Die Pharmazie 2004;59(9):692-9.
2003: Anne H de Boer; Paul Hagedoorn; Henderik W Frijlink
The choice of a compressor for the aerosolisation of tobramycin (TOBI) with the PARI LC PLUS reusable nebuliser.
International journal of pharmaceutics 2003;268(1-2):59-69.
2003: Anne H de Boer; Paul Hagedoorn; Doetie Gjaltema; J Goede; K D Kussendrager; Henderik W Frijlink
Air classifier technology (ACT) in dry powder inhalation. Part 2. The effect of lactose carrier surface properties on the drug-to-carrier interaction in adhesive mixtures for inhalation.
International journal of pharmaceutics 2003;260(2):201-16.
2003: Anne H de Boer; Paul Hagedoorn; Doetie Gjaltema; J Goede; Henderik W Frijlink
Air classifier technology (ACT) in dry powder inhalation. Part 1. Introduction of a novel force distribution concept (FDC) explaining the performance of a basic air classifier on adhesive mixtures.
International journal of pharmaceutics 2003;260(2):187-200.
2002: Anne H de Boer; Doetie Gjaltema; Paul Hagedoorn; M Schaller; W Witt; Henderik W Frijlink
Design and application of a new modular adapter for laser diffraction characterization of inhalation aerosols.
International journal of pharmaceutics 2002;249(1-2):233-45.
2002: Anne H de Boer; Doetie Gjaltema; Paul Hagedoorn; Henderik W Frijlink
Characterization of inhalation aerosols: a critical evaluation of cascade impactor analysis and laser diffraction technique.
International journal of pharmaceutics 2002;249(1-2):219-31.
2002: Anne H de Boer; P P H Le Brun; H G van der Woude; Paul Hagedoorn; Harry G M Heijerman; Henderik W Frijlink
Dry powder inhalation of antibiotics in cystic fibrosis therapy, part 1: development of a powder formulation with colistin sulfate for a special test inhaler with an air classifier as de-agglomeration principle.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2002;54(1):17-24.
1999: P P H Le Brun; Anne H de Boer; Doetie Gjaltema; Paul Hagedoorn; Harry G M Heijerman; Henderik W Frijlink
Inhalation of tobramycin in cystic fibrosis. Part 2: optimization of the tobramycin solution for a jet and an ultrasonic nebulizer.
International journal of pharmaceutics 1999;189(2):215-25.
1999: P P H Le Brun; Anne H de Boer; Doetie Gjaltema; Paul Hagedoorn; Harry G M Heijerman; Henderik W Frijlink
Inhalation of tobramycin in cystic fibrosis. Part 1: the choice of a nebulizer.
International journal of pharmaceutics 1999;189(2):205-14.